Genotyping Panel Accurately Identifies Biomarkers for Solid Cancers in Plasma Genotyping Panel Accurately Identifies Biomarkers for Solid Cancers in Plasma

A highly sensitive cell-free DNA (cfDNA) sequencing-based method allows simultaneous determination of microsatellite instability (MSI) status and genomic biomarkers for solid cancers in plasma, researchers report.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news